The content on this site is intended for healthcare professionals only
Dr Jean-Francois Dufour discusses the management of hepatocellular carcinoma and explains which preventative measures are being used to reduce the incidence of this disease.
Dr Dufour explains what factors are important in tumour assessment, how patients can be stratified based on these assessments, and how each of these different patient sub-groups should be treated.
The outcomes of some key clinical trials assessing different treatment options are discussed and areas are highlighted where available treatment options are insufficient.
Gaza's cancer patients: Navigating the dual struggle of illness and war
Cancer in emergencies: What can we do better to protect the most vulnerable?
Powering equity in cancer care through digital health
Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours
Selecting patients wisely for neoadjuvant therapy in HPB cancers
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies
Psychological issues in familial cancer
Multiple myeloma In Rwanda: The need for further research
GIST tumours and soft tissue sarcomas
